MSTR arrives at its July 30 earnings release with a notable shift in the options picture — the call-heavy defensive reversal documented in Monday's note has unwound, and flow has rotated back toward calls even as the stock slipped back below $100.
The options signal is the week's most interesting development. The put/call ratio has dropped sharply to 0.93, nearly two standard deviations below its 20-day average of 1.00 — reversing the more defensive 1.04 reading flagged in Monday's earnings preview. That's a fast move. Two weeks ago this column noted the same call-heavy tilt; it briefly turned defensive mid-week, and has now snapped back. The 52-week PCR range runs from 0.76 to 1.44, so at 0.93 the market is leaning toward upside exposure heading into the print. The borrow market corroborates a broadly relaxed setup: availability has widened to 303% of short interest, up 17% on the week, comfortably above the 52-week floor of 132%. Cost to borrow has eased 16% on the week to 0.47%, a multi-month low. None of that signals squeeze pressure.
Short interest itself continues its steady retreat and no longer demands headline treatment on its own. Bears hold roughly 38.9 million shares short, equal to 14.5% of the free float — down 2.8% on the week and off more than 6% over the past month from the 41.6 million peak in late June. The direction of travel is clear: shorts have been trimming consistently for six weeks. At 14.5% the position remains elevated in absolute terms, but the trend is not building.
The Street is broadly bullish while quietly marking down ambitions. Consensus sits at Buy, with a mean target near $304 — well above the current $96.16 close, though that gap reflects a round of aggressive target cuts through late June and early July. Multiple firms slashed targets by 30–40% in that period while keeping positive ratings, a pattern suggesting analysts still believe in the bitcoin treasury thesis but are recalibrating entry assumptions after the stock's 40%-plus year-to-date decline. Barclays initiated at Overweight on July 8 with a $130 target, the most recent fresh view and notable for being set close to current levels rather than in the stratosphere. EPS surprise ranks in the 81st percentile — the company has a track record of beating estimates — and the analyst recommendation differential scores in the 93rd percentile, meaning the Street is more bullish on MSTR relative to peers than on almost any other stock in the universe.
Institutional flows add a constructive undertone. Capital Research added 12.8 million shares in the quarter to June 30, lifting its stake to 12.1% of the company. BlackRock added 3.1 million shares over the same period. Founder Michael Saylor holds 5.6% with negligible change. The insider picture is less clean: director Jarrod Patten has sold small tranches consistently through June and July, and the CEO and CFO both sold modest amounts in early June. None of these are large in dollar terms — Patten's recent sales total roughly $500k — but the pattern of executive selling into a falling stock is worth noting alongside the institutional buying.
Recent earnings history offers thin guidance on magnitude but not direction: the last print produced a 1-day move of just +1.6%, and the print before that fell 2.8% on day one before recovering 8.9% over five days. The earnings release tonight will focus far less on software revenues and far more on bitcoin NAV, capital structure activity under the new authorization to buy back preferred and common equity, and any update to the accumulation cadence — those are the variables that move this stock, not the underlying software business.
See the live data behind this article on ORTEX.
Open MSTR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
